Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-12-15
1996-01-16
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 56, 514 57, 514 58, 514 59, 514 60, 536 59, 536109, 536112, 536118, 426658, 424439, A61K 3172
Patent
active
054847770
ABSTRACT:
This invention encompasses a method and compositions which inhibit pancreatic cholesterol esterase and triglyceride lipase and hence, lower cholesterol and triglycerides in the blood stream.
REFERENCES:
patent: 3148114 (1964-09-01), Fahrenbach et al.
patent: 3175942 (1965-03-01), Anderson et al.
patent: 3511910 (1970-05-01), Halleck
patent: 3627872 (1971-12-01), Parkinson
patent: 4066829 (1979-01-01), Nair et al.
patent: 4150110 (1979-04-01), Yoshida et al.
patent: 4160826 (1979-07-01), Fischetti
patent: 4223023 (1980-09-01), Furda
patent: 4436731 (1984-03-01), Maltz
patent: 4520017 (1985-05-01), Tunc
patent: 4602003 (1986-07-01), Malinow
patent: 4623539 (1986-11-01), Tunc
patent: 4727063 (1988-02-01), Naggi et al.
patent: 4883788 (1989-11-01), Day et al.
patent: 5017565 (1991-05-01), Lange, III et al.
Cook et al; Arch. Int. Pharmacodyn. 144(1-2)11-19 (1963).
Mokady; Nutr. Metabol. 15:290-294 (1973).
Hoffman et al; Carb. Polym. 2:115-121 (1982).
Goto et al; J. Clin. Biochem. Nutr. 2:55-70 (1987).
Bosner et al; PNAS 85:7438-7442 (Oct. 1988).
Jansen et al; Biochem. Biophys. Res. Commun. 92(1):53-59 (1980).
Superko; Cardiovasc: Rev. Reports 6(11):1253-4, 1257-8, 1263-5 (1985).
Fernandez et al; Biochim. Biophys. Acta 1001:249-255 (1989).
Ogawa et al; Chem. Pharm. Bull. 34:1118-1127; 35:3276-3283; 4130-4136 (1986-1987).
Morin et al; Biochim. Biophys. ACTA 1004: 139-142 (1989).
Seethanathan et al; Mol. & Cell, Biochem. 8:177-183 (1975).
Hadvary et al; Int. J. Obesity 11(suppl 2):21 (1987).
Vahouny et al; Proc. J. Exp. Biol. Med. 116:496 (1964).
Calame et al; Arch. Biochem. Biophys. 168:57-65 (1975).
Van Den Bosch et al; Biochem. Biophys. ACTA 296:94-104 (1973).
Momsen et al; Biochem. Biophys. ACTA 486:103-113 (1977).
Guy et al; Eur. J. Biochem. 117:457-460 (1981).
Sutton et al; Biochem. Biophys. Res. Commun. 134:386-392 (1986).
Larm et al; Carb. Res. 73:332-336 (1979).
Bosner et al; Clin. Res. 37:366A (1989).
Borja et al; Am. J. Physiol. 206:223-228 (1964).
AMA Drug Evaluations 6th Ed. pp. 903-926.
JAMA 253:2080-2085 (1985).
Harlan et al, JAMA 253:2087-2090 (1985).
Kronmal; JAMA 253:2091-2093 (1985).
Rahimtoola; JAMA 253:2094-2095 (1985).
Arch. Intern. Med. 148:36-39 (1988).
Barnes et al; Am. J. Surg. 113: 27-31 (1967).
Lange, III Louis G.
Spilburg Curtis A.
Fonda Kathleen Kahler
Robinson Douglas W.
LandOfFree
Pancreatic cholesterol esterase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pancreatic cholesterol esterase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pancreatic cholesterol esterase inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-309443